|
1
|
Li Y, Feng D, Wang Z, Zhao Y, Sun R, Tian
D, Liu D, Zhang F, Ning S, Yao J and Tian X: Ischemia-induced ACSL4
activation contributes to ferroptosis-mediated tissue injury in
intestinal ischemia/reperfusion. Cell Death Differ. 26:2284–2299.
2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sun Y, Lian M, Lin Y, Xu B, Li Y, Wen J,
Chen D, Xu M, Almoiliqy M and Wang L: Role of p-MKK7 in
myricetin-induced protection against intestinal
ischemia/reperfusion injury. Pharmacol Res. 129:432–442.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Karhausen J, Bernstock JD, Johnson KR,
Sheng H, Ma Q, Shen Y, Yang W, Hallenbeck JM and Paschen W: Ubc9
overexpression and SUMO1 deficiency blunt inflammation after
intestinal ischemia/reperfusion. Lab Invest. 98:799–813.
2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Leone M, Bechis C, Baumstarck K, Ouattara
A, Collange O, Augustin P, Annane D, Arbelot C, Asehnoune K,
Baldési O, et al: Outcome of acute mesenteric ischemia in the
intensive care unit: A retrospective, multicenter study of 780
cases. Intensive Care Med. 41:667–676. 2015.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Liu ZM, Zhang XY, Chen J, Shen JT, Jiang
ZY and Guan XD: Terlipressin protects intestinal epithelial cells
against oxygen-glucose deprivation/re-oxygenation injury via the
phosphatidylinositol 3-kinase pathway. Exp Ther Med. 14:260–266.
2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Yu JS, Yan S, Liu XS, Wu YJ, Fu PF, Wu LH
and Zheng SS: Attenuation of graft ischemia-reperfusion injury by
urinary trypsin inhibitor in mouse intestinal transplantation.
World J Gastroenterol. 11:1605–1609. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Daniel RA, Cardoso VK, Góis E Jr, Parra
RS, Garcia SB, Rocha JJ and Féres O: Effect of hyperbaric oxygen
therapy on the intestinal ischemia reperfusion injury. Acta Cir
Bras. 26:463–469. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Miyake H, Koike Y, Seo S, Lee C, Li B,
Ganji N and Pierro A: The effect of pre- and post-remote ischemic
conditioning reduces the injury associated with intestinal
ischemia/reperfusion. Pediatr Surg Int. 36:1437–1442.
2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Feinman R, Deitch EA, Watkins AC, Abungu
B, Colorado I, Kannan KB, Sheth SU, Caputo FJ, Lu Q, Ramanathan M,
et al: HIF-1 mediates pathogenic inflammatory responses to
intestinal ischemia-reperfusion injury. Am J Physiol Gastrointest
Liver Physiol. 299:G833–G843. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang G, Yao J, Li Z, Zu G, Feng D, Shan W,
Li Y, Hu Y, Zhao Y and Tian X: miR-34a-5p inhibition alleviates
intestinal ischemia/reperfusion-induced reactive oxygen species
accumulation and apoptosis via activation of SIRT1 signaling.
Antioxid Redox Signal. 24:961–973. 2016.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rodriguez-Lara SQ, Cardona-Muñoz EG,
Ramirez-Lizardo EJ, Totsuka-Sutto SE, Castillo-Romero A,
García-Cobián TA and García-Benavides L: Alternative interventions
to prevent oxidative damage following ischemia/reperfusion. Oxid
Med Cell Longev. 2016(7190943)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Pérez S, Taléns-Visconti R, Rius-Pérez S,
Finamor I and Sastre J: Redox signaling in the gastrointestinal
tract. Free Radic Biol Med. 104:75–103. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ameli M, Hashemi MS, Moghimian M and
Shokoohi M: Protective effect of tadalafil and verapamil on
testicular function and oxidative stress after torsion/detorsion in
adult male rat. Andrologia. 50(e13068)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
de Groot H and Rauen U:
Ischemia-reperfusion injury: Processes in pathogenetic networks: A
review. Transplant Proc. 39:481–484. 2007.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zu G, Guo J, Che N, Zhou T, Zhang X, Wang
G, Ji A and Tian X: Protective effects of ginsenoside Rg1 on
intestinal ischemia/reperfusion injury-induced oxidative stress and
apoptosis via activation of the Wnt/β-catenin pathway. Sci Rep.
6(38480)2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Sandborn WJ, Ghosh S, Panes J, Vranic I,
Su C, Rousell S and Niezychowski W: Study A3921063 Investigators.
Tofacitinib, an oral janus kinase inhibitor, in active ulcerative
colitis. N Engl J Med. 367:616–624. 2012.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lechner K, Gerlach K, Popp V, Offensperger
L, Zundler S, Wiendl M, Becker E, Atreya R, Rath T, Neurath MF and
Weigmann B: The JAK1/3 inhibitor tofacitinib suppresses T cell
homing and activation in chronic intestinal inflammation. J Crohns
Colitis: Aug 18, 2020 (Epub ahead of print).
|
|
18
|
Sayoc-Becerra A, Krishnan M, Fan S,
Jimenez J, Hernandez R, Gibson K, Preciado R, Butt G and McCole DF:
The JAK-inhibitor tofacitinib rescues human intestinal epithelial
cells and colonoids from cytokine-induced barrier dysfunction.
Inflamm Bowel Dis. 26:407–422. 2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Flanagan ME, Blumenkopf TA, Brissette WH,
Brown MF, Casavant JM, Shang-Poa C, Doty JL, Elliott EA, Fisher MB,
Hines M, et al: Discovery of CP-690,550: A potent and selective
janus kinase (JAK) inhibitor for the treatment of autoimmune
diseases and organ transplant rejection. J Med Chem. 53:8468–8484.
2010.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Danese S, Grisham M, Hodge J and Telliez
JB: JAK inhibition using tofacitinib for inflammatory bowel disease
treatment: A hub for multiple inflammatory cytokines. Am J Physiol
Gastrointest Liver Physiol. 310:G155–G162. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Clark JD, Flanagan ME and Telliez JB:
Discovery and development of janus kinase (JAK) inhibitors for
inflammatory diseases. J Med Chem. 57:5023–5038. 2014.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhang H, Liu X, Yang F, Cheng D and Liu W:
Overexpression of HIF-1α protects PC12 cells against OGD/R-evoked
injury by reducing miR-134 expression. Cell Cycle. 19:990–999.
2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fang H, Zhang FX, Li HF, Yang M, Liao R,
Wang RR, Wang QY, Zheng PC and Zhang JP: PRR34-AS1 overexpression
promotes protection of propofol pretreatment against
ischemia/reperfusion injury in a mouse model after total knee
arthroplasty via blockade of the JAK1-dependent JAK-STAT signaling
pathway. J Cell Physiol. 235:2545–2556. 2020.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhang XK, Zhou XP, Zhang Q and Zhu F: The
preventive effects of dexmedetomidine against intestinal
ischemia-reperfusion injury in wistar rats. Iran J Basic Med Sci.
18:604–609. 2015.PubMed/NCBI
|
|
25
|
Zhao H, Feng Y, Wei C, Li Y, Ma H, Wang X,
Cui Z, Jin WN and Shi FD: Colivelin rescues ischemic neuron and
axons involving JAK/STAT3 signaling pathway. Neuroscience.
416:198–206. 2019.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhou J, Huang WQ, Li C, Wu GY, Li YS, Wen
SH, Lei WL and Liu KX: Intestinal ischemia/reperfusion enhances
microglial activation and induces cerebral injury and memory
dysfunction in rats. Crit Care Med. 40:2438–2448. 2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vollmar B and Menger MD: Intestinal
ischemia/reperfusion: Microcirculatory pathology and functional
consequences. Langenbecks Arch Surg. 396:13–29. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dai H, Wang M, Patel PN, Kalogeris T, Liu
Y, Durante W and Korthuis RJ: Preconditioning with the
BKCa channel activator NS-1619 prevents
ischemia-reperfusion-induced inflammation and mucosal barrier
dysfunction: Roles for ROS and heme oxygenase-1. Am J Physiol Heart
Circ Physiol. 313:H988–H999. 2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lin ZL, Tan SJ, Cheng MH, Zhao CY, Yu WK,
He YL, Li J and Li N: Lipid-rich enteral nutrition controls
intestinal inflammation, improves intestinal motility and mucosal
barrier damage in a rat model of intestinal ischemia/reperfusion
injury. J Surg Res. 213:75–83. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ikeda H, Suzuki Y, Suzuki M, Koike M,
Tamura J, Tong J, Nomura M and fItoh G: Apoptosis is a major mode
of cell death caused by ischaemia and ischaemia/reperfusion injury
to the rat intestinal epithelium. Gut. 42:530–537. 1998.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Shen JT, Li YS, Xia ZQ, Wen SH, Yao X,
Yang WJ, Li C and Liu KX: Remifentanil preconditioning protects the
small intestine against ischemia/reperfusion injury via intestinal
δ- and µ-opioid receptors. Surgery. 159:548–559. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Eltzschig HK and Eckle T: Ischemia and
reperfusion-from mechanism to translation. Nat Med. 17:1391–1401.
2011.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Li LX, Yin LH, Gao M, Xu LN, Qi Y and Peng
JY: MiR-23a-5p exacerbates intestinal ischemia-reperfusion injury
by promoting oxidative stress via targeting PPAR alpha. Biochem
Pharmacol. 180(114194)2020.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Wu MB, Ma B, Zhang TX, Zhao K, Cui SM and
He SC: Propofol improves intestinal ischemia-reperfusion injury in
rats through NF-κB pathway. Eur Rev Med Pharmacol Sci.
24:6463–6469. 2020.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Yang X, Wan M, Cheng Z, Wang Z and Wu Q:
Tofacitinib inhibits ox-LDL-induced adhesion of THP-1 monocytes to
endothelial cells. Artif Cell Nanomed Biotechnol. 47:2775–2782.
2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang AL, Niu Q, Shi N, Wang J, Jia XF,
Lian HF, Liu Z and Liu CX: Glutamine ameliorates intestinal
ischemia-reperfusion injury in rats by activating the Nrf2/Are
signaling pathway. Int J Clin Exp Pathol. 8:7896–7904.
2015.PubMed/NCBI
|
|
37
|
Wang H, Cai D, Chen Z and Wang Y: GTS-21
promotes α7 nAChR to alleviate intestinal
ischemia-reperfusion-induced apoptosis and inflammation of
enterocytes. Med Sci Monit. 26(e921618)2020.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Meng QT, Chen R, Chen C, Su K, Li W, Tang
LH, Liu HM, Xue R, Sun Q, Leng Y, et al: Transcription factors Nrf2
and NF-κB contribute to inflammation and apoptosis induced by
intestinal ischemia-reperfusion in mice. Int J Mol Med.
40:1731–1740. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lee EB, Fleischmann R, Hall S, Wilkinson
B, Bradley JD, Gruben D, Koncz T, Krishnaswami S, Wallenstein GV,
Zang C, et al: Tofacitinib versus methotrexate in rheumatoid
arthritis. N Engl J Med. 370:2377–2386. 2014.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Palasik BN and Wang HM: Tofacitinib, the
first oral janus kinase inhibitor approved for adult ulcerative
colitis. J Pharm Pract: Sep 2, 2020 (Online ahead of print).
|
|
41
|
Liu W, Singh SR and Hou SX: JAK-STAT is
restrained by notch to control cell proliferation of the drosophila
intestinal stem cells. J Cell Biochem. 109:992–999. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Lu KH, Wu HH, Lin RC, Lin YC, Lu PW, Yang
SF and Yang JS: Curcumin analogue L48H37 suppresses human
osteosarcoma U2OS and MG-63 Cells' migration and invasion in
culture by inhibition of uPA via the JAK/STAT signaling pathway.
Molecules. 26(30)2020.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yue Y, Zhang Q, Wu S, Wang S, Cui C, Yu M
and Sun Z: Identification of key genes involved in JAK/STAT pathway
in colorectal cancer. Mol Immunol. 128:287–297. 2020.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Feng P, Zhang A, Su M, Cai H, Wang X and
Zhang Y: Dexmedetomidine inhibits apoptosis of astrocytes induced
by oxygen-glucose deprivation via targeting JAK/STAT3 signal
pathway. Brain Res. 1750(147141)2021.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lin Z, Rn J and Shan X: Fish oils protects
against cecal ligation and puncture-induced septic acute kidney
injury via the regulation of inflammation, oxidative stress and
apoptosis. Int J Mol Med. 44:1771–1780. 2019.PubMed/NCBI View Article : Google Scholar
|
